Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy

NCT02580279 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Dermatitis
Prevention & Control
Epigallocatechin Gallate

Interventions

DRUG: EGCG
DRUG: placebo

Sponsor

Shandong Cancer Hospital and Institute